Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients

This study has been terminated.

( Commercial reasons )

Study NCT00642421 Information provided by Ambrilia Biopharma, Inc.

First Received: March 21, 2008 Last Updated: February 7, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	August 2009
Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)